Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer Reports is Scopus-indexed (Q3, CiteScore 3.7), WoS ESCI, DOAJ. Published by Wiley-Blackwell Publishing Ltd.
Checked against the index lists dated .
ISSN 2573-8348Verify ISSN ↗
Publisher: Wiley-Blackwell Publishing Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 233 / 428 | 45th | Q3 |
| Cancer Research | 165 / 233 | 29th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2018–present, best quartile Q3, CiteScore 3.7.
Cancer Reports is Q3 in Oncology (rank 233 of 428) and Q3 in Cancer Research (rank 165 of 233), by CiteScore 2025.
Cancer Reports is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.7, which places it in quartile Q3 at the 45th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.707, quartile Q3, with an H-index of 30.
The publisher lists an article processing charge of about US$3,280 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cancer Reports is published by Wiley-Blackwell Publishing Ltd. Its ISSN is 2573-8348.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Cancer Reports has an h-index of 32 and a 2-year mean of 1.55 citations per paper (OpenAlex). Its Scopus CiteScore is 3.7, quartile Q3. On 2-year citations it ranks #237 of 424 Scopus journals in Oncology.
Cancer Reports published 354 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from China (21.7%), Japan (13.1%) and United States (12.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.